Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18292 | 558 | 42.7 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
363 | 2 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 17354 |
18292 | 1 | ACYLATION STIMULATING PROTEIN//C3ADESARG//RGC 32 | 558 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACYLATION STIMULATING PROTEIN | authKW | 2318701 | 9% | 85% | 50 |
2 | C3ADESARG | authKW | 1261808 | 5% | 82% | 28 |
3 | RGC 32 | authKW | 737298 | 3% | 84% | 16 |
4 | MIKE ROSENBLOOM CARDIOVASC | address | 532024 | 6% | 29% | 33 |
5 | ACYLATION STIMULATING PROTEIN ASP | authKW | 328330 | 1% | 100% | 6 |
6 | RESPONSE GENE TO COMPLEMENT 32 | authKW | 318376 | 1% | 73% | 8 |
7 | C5L2 | authKW | 237909 | 2% | 43% | 10 |
8 | ENZYMATICALLY MODIFIED LDL | authKW | 228005 | 1% | 83% | 5 |
9 | ADIPSIN | authKW | 174230 | 2% | 29% | 11 |
10 | TRIGLYCERIDE SYNTHESIS | authKW | 154112 | 2% | 22% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 1938 | 18% | 0% | 99 |
2 | Endocrinology & Metabolism | 1402 | 20% | 0% | 112 |
3 | Nutrition & Dietetics | 621 | 9% | 0% | 52 |
4 | Cardiac & Cardiovascular System | 573 | 14% | 0% | 76 |
5 | Hematology | 357 | 8% | 0% | 47 |
6 | Biochemistry & Molecular Biology | 314 | 23% | 0% | 129 |
7 | Immunology | 217 | 11% | 0% | 62 |
8 | Medicine, Research & Experimental | 147 | 7% | 0% | 40 |
9 | Medical Laboratory Technology | 121 | 3% | 0% | 15 |
10 | Pathology | 58 | 4% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MIKE ROSENBLOOM CARDIOVASC | 532024 | 6% | 29% | 33 |
2 | RECH HOP LAVAL | 140077 | 1% | 32% | 8 |
3 | MCGILL UNIT PREVENT CARDIOVASC DIS | 125075 | 1% | 57% | 4 |
4 | RECH IUCPQ | 123122 | 1% | 75% | 3 |
5 | RECH UNIV CARDIOL PNEUMOL QUEBEC | 123110 | 2% | 25% | 9 |
6 | SECT NUTR EPIDEMIOL | 116728 | 1% | 27% | 8 |
7 | CRIUCPQ | 91196 | 1% | 33% | 5 |
8 | BIOL HORMONE ACT | 54722 | 0% | 100% | 1 |
9 | BODY COMPOSITION METAB | 54722 | 0% | 100% | 1 |
10 | CIBERDEMURLA | 54722 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 5316 | 5% | 0% | 27 |
2 | REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE | 4776 | 1% | 3% | 3 |
3 | ATHEROSCLEROSIS | 4307 | 5% | 0% | 29 |
4 | MOLECULAR IMMUNOLOGY | 1729 | 3% | 0% | 15 |
5 | EXPERIMENTAL AND MOLECULAR PATHOLOGY | 1650 | 2% | 0% | 9 |
6 | INTERNATIONAL JOURNAL OF OBESITY | 1563 | 3% | 0% | 14 |
7 | ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS | 1548 | 0% | 1% | 2 |
8 | JOURNAL OF LIPID RESEARCH | 1424 | 3% | 0% | 15 |
9 | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 968 | 2% | 0% | 9 |
10 | OBESITY RESEARCH | 894 | 1% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACYLATION STIMULATING PROTEIN | 2318701 | 9% | 85% | 50 | Search ACYLATION+STIMULATING+PROTEIN | Search ACYLATION+STIMULATING+PROTEIN |
2 | C3ADESARG | 1261808 | 5% | 82% | 28 | Search C3ADESARG | Search C3ADESARG |
3 | RGC 32 | 737298 | 3% | 84% | 16 | Search RGC+32 | Search RGC+32 |
4 | ACYLATION STIMULATING PROTEIN ASP | 328330 | 1% | 100% | 6 | Search ACYLATION+STIMULATING+PROTEIN+ASP | Search ACYLATION+STIMULATING+PROTEIN+ASP |
5 | RESPONSE GENE TO COMPLEMENT 32 | 318376 | 1% | 73% | 8 | Search RESPONSE+GENE+TO+COMPLEMENT+32 | Search RESPONSE+GENE+TO+COMPLEMENT+32 |
6 | C5L2 | 237909 | 2% | 43% | 10 | Search C5L2 | Search C5L2 |
7 | ENZYMATICALLY MODIFIED LDL | 228005 | 1% | 83% | 5 | Search ENZYMATICALLY+MODIFIED+LDL | Search ENZYMATICALLY+MODIFIED+LDL |
8 | ADIPSIN | 174230 | 2% | 29% | 11 | Search ADIPSIN | Search ADIPSIN |
9 | TRIGLYCERIDE SYNTHESIS | 154112 | 2% | 22% | 13 | Search TRIGLYCERIDE+SYNTHESIS | Search TRIGLYCERIDE+SYNTHESIS |
10 | COMPLEMENT C3A | 148956 | 1% | 39% | 7 | Search COMPLEMENT+C3A | Search COMPLEMENT+C3A |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VLAICU, SI , TATOMIR, A , BOODHOO, D , VESA, S , MIRCEA, PA , RUS, H , (2016) THE ROLE OF COMPLEMENT SYSTEM IN ADIPOSE TISSUE-RELATED INFLAMMATION.IMMUNOLOGIC RESEARCH. VOL. 64. ISSUE 3. P. 653 -664 | 75 | 63% | 3 |
2 | HERTLE, E , STEHOUWER, CDA , VAN GREEVENBROEK, MMJ , (2014) THE COMPLEMENT SYSTEM IN HUMAN CARDIOMETABOLIC DISEASE.MOLECULAR IMMUNOLOGY. VOL. 61. ISSUE 2. P. 135 -148 | 87 | 42% | 17 |
3 | VLAICU, SI , TATOMIR, A , RUS, V , MEKALA, AP , MIRCEA, PA , NICULESCU, F , RUS, H , (2016) THE ROLE OF COMPLEMENT ACTIVATION IN ATHEROGENESIS: THE FIRST 40 YEARS.IMMUNOLOGIC RESEARCH. VOL. 64. ISSUE 1. P. 1 -13 | 59 | 48% | 3 |
4 | ONAT, A , CAN, G , REZVANI, R , CIANFLONE, K , (2011) COMPLEMENT C3 AND CLEAVAGE PRODUCTS IN CARDIOMETABOLIC RISK.CLINICA CHIMICA ACTA. VOL. 412. ISSUE 13-14. P. 1171-1179 | 50 | 54% | 32 |
5 | BARBU, A , HAMAD, OA , LIND, L , EKDAHL, KN , NILSSON, B , (2015) THE ROLE OF COMPLEMENT FACTOR C3 IN LIPID METABOLISM.MOLECULAR IMMUNOLOGY. VOL. 67. ISSUE 1. P. 101 -107 | 43 | 51% | 10 |
6 | SALEH, J , AL-WARDY, N , FARHAN, H , AL-KHANBASHI, M , CIANFLONE, K , (2011) ACYLATION STIMULATING PROTEIN: A FEMALE LIPOGENIC FACTOR?.OBESITY REVIEWS. VOL. 12. ISSUE 6. P. 440 -448 | 45 | 58% | 8 |
7 | CIANFLONE, K , XIA, ZN , CHEN, LY , (2003) CRITICAL REVIEW OF ACYLATION-STIMULATING PROTEIN PHYSIOLOGY IN HUMANS AND RODENTS.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1609. ISSUE 2. P. 127-143 | 66 | 37% | 205 |
8 | LIU, Y , GUPTA, P , LAPOINTE, M , YOTSAPON, T , SARAT, S , CIANFLONE, K , (2014) ACYLATION STIMULATING PROTEIN, COMPLEMENT C3 AND LIPID METABOLISM IN KETOSIS-PRONE DIABETIC SUBJECTS.PLOS ONE. VOL. 9. ISSUE 10. P. - | 31 | 72% | 1 |
9 | PAGLIALUNGA, S , FISETTE, A , YAN, YF , DESHAIES, Y , BROUILLETTE, JF , PEKNA, M , CIANFLONE, K , (2008) ACYLATION-STIMULATING PROTEIN DEFICIENCY AND ALTERED ADIPOSE TISSUE IN ALTERNATIVE COMPLEMENT PATHWAY KNOCKOUT MICE.AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. VOL. 294. ISSUE 3. P. E521-E529 | 31 | 78% | 20 |
10 | GUPTA, A , REZVANI, R , LAPOINTE, M , POURSHARIFI, P , MARCEAU, P , TIWARI, S , TCHERNOF, A , CIANFLONE, K , (2014) DOWNREGULATION OF COMPLEMENT C3 AND C3AR EXPRESSION IN SUBCUTANEOUS ADIPOSE TISSUE IN OBESE WOMEN.PLOS ONE. VOL. 9. ISSUE 4. P. - | 31 | 67% | 3 |
Classes with closest relation at Level 1 |